Newsroom Navigation

Contact Info:
Office of Public Affairs
2000 Circle of Hope,
Salt Lake City, UT 84112

public.affairs@hci.utah.edu

801-587-7639

Press Releases

The Pancreatic Cancer Collective awards $7 million in first-round “New Therapies Challenge” Grants
Press Releases

The Pancreatic Cancer Collective awards $7 million in first-round “New Therapies Challenge” Grants

The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded a total of $7 million in first-round “New Therapies Challenge” grants to seven teams of top cancer researchers to explore new pancreatic cancer treatments, the American Association for Cancer Research, the Scientific Partner of SU2C, announced today. Each team will receive up to $1 million in initial funding, with $4 million per team for clinical studies awaiting the most successful projects in the second round.

Read More

Huntsman Cancer Institute Breaks Ground for Utah’s First Proton Therapy Center
Press Releases

Huntsman Cancer Institute Breaks Ground for Utah’s First Proton Therapy Center

Today officials at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) began construction on a project that will house the region’s first proton therapy center and announced the new center will be named in honor of United States Senator Orrin G. Hatch. Cancer patients and loved ones joined leaders from HCI, Huntsman Cancer Foundation (HCF), and the U of U to mark the occasion.

Read More

Let’s Talk About Your DNA
Press Releases

Let’s Talk About Your DNA

An interdisciplinary team of researchers at Huntsman Cancer Institute (HCI) at the University of Utah (the university) was recently awarded a prestigious team science grant through the National Cancer Institute’s (NCI) Cancer Moonshot initiative to study genetic counseling, genetic communication and genetic services to patients. The grant is expected to provide more than $5 million in research project support over the next five years.

Read More

Utah Cancer Registry Receives Renewal from National Cancer Institute
Press Releases

Utah Cancer Registry Receives Renewal from National Cancer Institute

Huntsman Cancer Institute (HCI) and the University of Utah (U of U) will receive up to $28 million over the next 10 years from the National Cancer Institute (NCI) to continue its participation in the NCI’s Surveillance Epidemiology and End Results (SEER) program, if all contract options are exercised. The work is conducted through the Utah Cancer Registry (UCR) at the U of U, in collaboration with the Utah Department of Health.

Read More

A Bad Influence: The Interplay between Tumor Cells and Immune Cells
Press Releases

A Bad Influence: The Interplay between Tumor Cells and Immune Cells

Research at Huntsman Cancer Institute at the University of Utah yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ultimately affect response to treatment. The results were published today in Immunity and featured on the print cover of the journal.

Read More

Study Holds Promise for New Pediatric Brain Tumor Treatment
Press Releases

Study Holds Promise for New Pediatric Brain Tumor Treatment

- New research published in Nature Communications from scientists at Huntsman Cancer Institute (HCI) at the University of Utah (U of U), in collaboration with the Stanford University School of Medicine, shows a specific protein regulates both the initiation of cancer spreading and the self-renewal of cancer cells in medulloblastoma, a type of pediatric brain cancer.

Read More

Huntsman Cancer Institute and Grand Valley Oncology Begin Telemedicine Clinic for Blood and Bone Marrow Transplant Patients
Press Releases

Huntsman Cancer Institute and Grand Valley Oncology Begin Telemedicine Clinic for Blood and Bone Marrow Transplant Patients

Huntsman Cancer Institute at the University of Utah, in partnership with Grand Valley Oncology, recently opened a telemedicine clinic to serve blood and marrow transplant patients in Mesa County, Colorado and the surrounding areas. This service will bring cutting-edge care to remote communities without requiring the patient to travel long distances to Salt Lake City for follow-up appointments.

Read More

Research Identifies New Treatment Targets in Breast Cancer
Press Releases, HCI News

Research Identifies New Treatment Targets in Breast Cancer

Scientists at Huntsman Cancer Institute (HCI) at the University of Utah (U of U), in collaboration with the Salk Institute for Biological Studies, have generated the first single cell resolution atlas of genes that control the formation of breast tissue. The atlas provides a comprehensive molecular map that will be used to help researchers understand how breast cancers form and to pinpoint new ways to prevent, diagnose, and treat the disease.

Read More

cancer, cancer research,

 Huntsman Cancer Institute Names Cornelia Ulrich as Director of its Cancer Research Center
Press Releases, HCI News

Huntsman Cancer Institute Names Cornelia Ulrich as Director of its Cancer Research Center

Huntsman Cancer Institute (HCI) at the University of Utah today announced the appointment of Cornelia Ulrich, PhD, MS, as director of its National Cancer Institute-Designated Comprehensive Cancer Center. She will oversee HCI’s academic consortium of nearly 200 cancer research teams. Ulrich will lead efforts to advance HCI’s research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment. – Huntsman Cancer Institute (HCI) at the University of Utah today announced the appointment of Cornelia Ulrich, PhD, MS, as director of its National Cancer Institute-Designated Comprehensive Cancer Center. She will oversee HCI’s academic consortium of nearly 200 cancer research teams. Ulrich will lead efforts to advance HCI’s research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment.

Read More

cancer, cancer research, u0991242

Huntsman Cancer Institute Researcher Receives Leadership Award from the National Cancer Institute
Press Releases, HCI News

Huntsman Cancer Institute Researcher Receives Leadership Award from the National Cancer Institute

Huntsman Cancer Institute (HCI) physician-scientist Ahmad Halwani, MD, has been selected by the National Cancer Institute (NCI) to receive a Cancer Clinical Investigator Team Leadership Award. This award recognizes physician-scientists for their contributions to clinical cancer research. It also provides financial support for ongoing research and leadership development to enable recipients to further advance their clinical research careers.

Read More

cancer, cancer research,

Huntsman Cancer Institute Partners with Nation’s Top Cancer Centers to Endorse Goal of Eliminating HPV Related Cancers in the United States
Press Releases, HCI News

Huntsman Cancer Institute Partners with Nation’s Top Cancer Centers to Endorse Goal of Eliminating HPV Related Cancers in the United States

Nearly 80 million Americans — one out of every four people — are infected with human papillomavirus (HPV). And of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the United States.

Read More

hpv, cancer, cancer research,

Huntsman Cancer Institute First Adult Cancer Hospital in Mountain West to Offer CAR T Cell Therapy to Patients
Press Releases, HCI News

Huntsman Cancer Institute First Adult Cancer Hospital in Mountain West to Offer CAR T Cell Therapy to Patients

Huntsman Cancer Institute announced today that it has been certified to offer both chimeric antigen receptor (CAR) T cell therapies recently approved by the U.S. Food and Drug Administration. The therapies are approved for types of aggressive blood cancers, including B-cell acute lymphoblastic leukemia and non-Hodgkin lymphoma. HCI is one of a few locations nationwide, and the only in the Mountain West, approved to offer these new therapies to adult cancer patients.

Read More

blood and marrow transplant, cancer care, cancer research, immunotherapy, leukemia, lymphoma

Huntsman Cancer Institute Opens Center for HOPE and is Awarded $9.7 Million to Improve Health Among Underserved Populations
Press Releases, HCI News

Huntsman Cancer Institute Opens Center for HOPE and is Awarded $9.7 Million to Improve Health Among Underserved Populations

Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients. The center recently received $9.7 million from the Patient-Centered Outcomes Research Institute (PCORI) to fund a clinical trial researching new and effective approaches to reduce tobacco use.

Read More

cancer research, center for hope, health equity

Persistence Pays Off in Discovery That Could Lead to Improved Treatment and Survivability of Patients with Brain Tumors
Press Releases, HCI News

Persistence Pays Off in Discovery That Could Lead to Improved Treatment and Survivability of Patients with Brain Tumors

Gliomas are the most common type of central nervous system cancer but how these tumors develop is not fully understood. Sheri Holmen, PhD a researcher at Huntsman Cancer Institute (HCI) and professor of surgery at the University of Utah just published the results of her research on gliomas in Cell Reports. The work is focused on a mutated gene that is a critical piece of the puzzle for glioma development, according to Holmen’s work.

Read More

Huntsman Cancer Institute Joins National Clinical Trial Targeting AML
Press Releases, HCI News

Huntsman Cancer Institute Joins National Clinical Trial Targeting AML

Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.

Read More

u0029004, u0866101, u0690004


Our media relations representatives are here to help reporters Monday-Friday, 7:30 am-5 pm.

Debby Rogers
Public Affairs Manager
Phone: 801-587-7639
debby.rogers@hci.utah.edu

Amie Parker
Public Relations Associate
Phone: 801-213-5755
amie.parker@hci.utah.edu

Jill Woods
Administrative Assistant
Phone: 801-585-5321
Fax: 801-585-0900
jill.woods@hci.utah.edu

After-hours calls: Reporters calling before or after business hours on an urgent matter can page the University of Utah Health on-call media relations representative at 801-581-7387 and press 1.